Glasziou P, Ogrinc G, Goodman S Can evidence-based medicine and clinical quality improvement learn from each other? BMJ Qual Saf. 2011 Apr;20 Suppl 1:i13-17. doi: 10.1136/bmjqs.2010.046524.
Mann KJ, Craig MS, Moses JM Quality improvement educational practices in pediatric residency programs: survey of pediatric program directors. Acad Pediatr. 2014 Jan-Feb;14(1):23-8. doi: 10.1016/j.acap.2012.11.003.
Ogrinc G, Headrick LA, Morrison LJ, Foster T Teaching and assessing resident competence in practice-based learning and improvement. J Gen Intern Med. 2004 May;19(5 Pt 2):496-500.
Wang Y-S, Wang H-Y, Shee DY Measuring e-learning systems success in an organizational context: Scale development and validation. Comput. Human Behav. 2007;23:1792-808.
Wutoh R, Boren SA, Balas EA eLearning: a review of Internet-based continuing medical education. J Contin Educ Health Prof. 2004 Winter;24(1):20-30. Review.
Evaluation of eLearning of Quality Improvement Methods
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
